METASTATIC LIVER CANCER
Clinical trials for METASTATIC LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LIVER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Living Drug' that hunts liver cancer cells
Disease control Recruiting nowThis study is testing a new type of immune cell therapy for adults with advanced liver cancer that cannot be removed by surgery or has returned after other treatments. Doctors will give patients specially engineered immune cells designed to find and attack cancer cells. The study…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists reprogram Patients' own cells to fight advanced liver cancer
Disease control Recruiting nowThis early-stage trial is testing a new personalized treatment called ECT204 T-cell therapy for adults with advanced liver cancer (hepatocellular carcinoma) that has not responded to at least two other treatments. Doctors collect a patient's own immune cells, genetically modify t…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for tough cancers: first human trial of experimental drug begins
Disease control Recruiting nowThis is the first human study of an experimental drug called ERX-315 for people with advanced solid tumors that have stopped responding to standard treatments. The main goal is to find a safe dose and understand how the body processes the drug. Researchers will also look for earl…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1 • Sponsor: EtiraRx Australia Pty Ltd • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC